Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies Torrey, H., Defusco, A., Baum, D., Rhabar, Z., Khodadoust, M., Kim, Y. H., Faustman, D. L. AMER ASSOC CANCER RESEARCH. 2018

View details for DOI 10.1158/2326-6074.TUMIMM17-B18

View details for Web of Science ID 000456801700070